Obstructive Uropathy- Management

Obstructive uropathy is a condition characterized by impaired urine flow due to obstruction anywhere along the urinary tract, resulting in increased pressure within the urinary system and potential damage to the kidneys. The obstruction may occur at any level, from the renal calyces to the urethra.

Obstructive uropathy contributes significantly to the burden of chronic kidney disease (CKD) because prolonged obstruction causes progressive renal parenchymal damage, interstitial fibrosis, and loss of kidney function. Early recognition and correction of the obstruction are essential to prevent irreversible renal impairment.

The causes of obstruction vary depending on the anatomical location and may include urinary stones, tumours, enlarged lymph nodes, retroperitoneal fibrosis, prostate enlargement, urethral strictures, and congenital abnormalities.

Epidemiology

Obstructive uropathy can occur in individuals of all ages, although the underlying causes vary with age and sex.

Common causes include:

• Congenital urinary tract abnormalities in children.

• Urinary stones in adults.

• Benign prostatic hyperplasia and malignancy in older men.

• Pelvic malignancies causing ureteric obstruction.

Obstructive uropathy is an important reversible cause of acute kidney injury and a preventable contributor to chronic kidney disease.

Risk factors

Risk factors depend on the underlying cause and include:

• Urinary stones

• Benign prostatic hyperplasia

• Prostate cancer

• Bladder tumours

• Ureteric tumours

• Pelvic malignancies

• Enlarged lymph nodes

• Retroperitoneal fibrosis

• Urethral strictures

• Congenital urinary tract abnormalities

• Neurogenic bladder

• Recurrent urinary tract infections

• Previous urinary tract surgery or instrumentation

Pathophysiology

Obstructive uropathy occurs when urine flow is impaired, leading to accumulation of urine proximal to the site of obstruction.

The effects depend on the location and duration of obstruction:

• Obstruction within the kidney causes dilatation of individual calyces.

• Obstruction at or distal to the renal pelvis causes diffuse dilatation of the collecting system, resulting in hydronephrosis.

• Ureteric obstruction causes accumulation of urine above the obstruction and may lead to hydroureter and hydronephrosis.

Persistent obstruction increases intrarenal pressure, reduces renal blood flow, and causes inflammatory changes within the kidney. Over time, this results in tubular atrophy, interstitial fibrosis, and progressive decline in renal function.

Clinical presentation

Clinical manifestations depend on whether obstruction is acute or chronic, partial or complete, unilateral or bilateral.

Some patients may remain asymptomatic until significant renal impairment develops.

Symptoms

Patients may present with one or more of the following:

• Flank pain

• Lower abdominal pain

• Change in urine output

• Reduced urine output (oliguria)

• Complete absence of urine output (anuria)

• Haematuria

• Difficulty passing urine

• Symptoms related to underlying cause, such as:

  • Renal colic due to stones

  • Lower urinary tract symptoms due to prostate enlargement

Clinical signs

Possible clinical findings include:

• Hypertension

• Palpable enlarged bladder in lower urinary tract obstruction

• Flank tenderness

• Features of dehydration or fluid overload

• Signs of underlying malignancy

• Reduced urine output

• Signs of renal impairment

Diagnostic criteria

Diagnosis is based on:

• Clinical evidence of urinary obstruction.

• Laboratory evidence of impaired kidney function.

• Imaging confirmation of obstruction.

Features supporting diagnosis include:

• Increased serum creatinine.

• Dilatation of urinary collecting system on imaging.

• Identification of the underlying obstructive cause.

Investigations

Urinalysis

Used to identify:

• Haematuria

• Urinary tract infection

• Proteinuria

• Crystals suggesting urinary stones

Blood investigations

Full blood count

May identify:

• Infection

• Anaemia associated with chronic disease or malignancy

Serum creatinine

Used to assess:

• Kidney function

• Severity of renal impairment

• Progression or recovery after relieving obstruction

Imaging investigations

Kidney, ureter, and bladder ultrasound (KUB ultrasound)

Used as an initial investigation to detect:

• Hydronephrosis

• Hydroureter

• Bladder distension

• Urinary stones

Intravenous pyelography

May be used to assess urinary tract anatomy and obstruction where available.

CT intravenous urography (CT IVU)

Provides detailed assessment of:

• Site of obstruction

• Underlying cause

• Stones

• Tumours

Magnetic resonance imaging (MRI)

Useful when:

• CT is contraindicated.

• Soft tissue abnormalities need evaluation.

Examination under anaesthesia

May be required in selected patients for:

• Evaluation of urethral or bladder pathology.

• Assessment of suspected malignancy or structural abnormalities.

Management

Management aims to:

1. Relieve obstruction.

2. Preserve kidney function.

3. Treat the underlying cause.

4. Prevent recurrence.

The approach depends on the location, severity, and cause of obstruction.

Non-pharmacological treatment

Relief of obstruction

Definitive management requires correction of the underlying cause, which may include:

• Ureteric stenting.

• Percutaneous nephrostomy.

• Surgical correction.

• Removal of urinary stones.

• Treatment of prostate obstruction.

• Management of tumours causing obstruction.

Measures to reduce recurrence risk

For patients with renal stones:

• Maintain adequate fluid intake to achieve approximately 2 litres of urine output daily.

Supportive care

• Monitor urine output.

• Monitor renal function.

• Manage fluid balance.

• Avoid nephrotoxic medications where possible.

Pharmacological treatment

Pharmacological treatment does not correct the obstruction but may provide symptom relief while definitive management is arranged.

Relief of pain

Non-steroidal anti-inflammatory drugs

• Diclofenac 100 mg orally as an initial dose, followed by 50 mg every 6–8 hours.

OR

Opioid analgesics

• Morphine 1–4 mg intravenously or subcutaneously every 1–4 hours as required for acute pain.

The dose may be increased up to 10 mg every 4 hours depending on pain severity and patient response.

Management according to underlying cause

Urinary stones

Management may include:

• Analgesia.

• Medical expulsive therapy where appropriate.

• Stone removal procedures when indicated.

Benign prostatic hyperplasia

Management includes:

• Relief of urinary retention.

• Medical therapy.

• Surgical intervention when required.

Malignancy-related obstruction

Management includes:

• Urological and oncology assessment.

• Relief of obstruction.

• Treatment of underlying cancer.

Retroperitoneal fibrosis

Management includes:

• Specialist evaluation.

• Ureteric stenting or surgical intervention where indicated.

Referral

Patients should be referred to a urologist for definitive treatment of the cause of obstruction.

Referral is particularly required for:

• Bilateral urinary obstruction.

• Obstruction in a solitary kidney.

• Rising serum creatinine.

• Persistent obstruction.

• Suspected malignancy.

• Need for surgical intervention.

• Recurrent obstruction.

Patients with impaired renal function may require long-term nephrology and urology follow-up.

Complications

• Acute kidney injury

• Chronic kidney disease

• Hydronephrosis

• Hydroureter

• Recurrent urinary tract infections

• Pyelonephritis

• Urosepsis

• Permanent loss of renal function

• Hypertension

• Electrolyte abnormalities

Prognosis

The prognosis depends on the duration, severity, and cause of obstruction.

Early relief of obstruction usually results in significant recovery of kidney function. However, prolonged or recurrent obstruction may cause irreversible renal damage and progression to chronic kidney disease.

Patients with bilateral obstruction, severe renal impairment, or delayed treatment have poorer outcomes.

Prevention

Prevention focuses on reducing recurrence and early detection of urinary tract problems:

• Maintain adequate fluid intake.

• Prevent recurrent urinary stones through dietary modification and appropriate treatment.

• Early evaluation of urinary symptoms.

• Regular follow-up of patients with prostate disease.

• Prompt management of urinary tract infections.

• Early investigation of haematuria.

• Avoid unnecessary urinary tract instrumentation.

• Monitor patients at risk of urinary obstruction.